Drug Patents owned by Septodont Holding

1. Drug name - ORAVERSE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7229630 SEPTODONT HOLDING Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof Jun, 2023

(8 months from now)

US7569230 SEPTODONT HOLDING Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof Oct, 2023

(1 year, 20 days from now)

US7575757 SEPTODONT HOLDING Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof Apr, 2025

(2 years from now)

Drugs and Companies using PHENTOLAMINE MESYLATE ingredient

Treatment: A method of reversing soft-tissue anesthesia i.e. anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic

Dosage: INJECTABLE;INJECTION

More Information on Dosage
Strength Dosage Availability
0.4MG/1.7ML INJECTABLE;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.